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Abstract. 
 
Integrin-linked kinase (ILK) is a multidomain
focal adhesion (FA) protein that functions as an impor-
tant regulator of integrin-mediated processes. We report
here the identiﬁcation and characterization of a new
calponin homology (CH) domain-containing ILK-bind-
ing protein (CH-ILKBP). CH-ILKBP is widely ex-
pressed and highly conserved among different organisms
from nematodes to human. CH-ILKBP interacts with
ILK in vitro and in vivo, and the ILK COOH-terminal
domain and the CH-ILKBP CH2 domain mediate the
interaction. CH-ILKBP, ILK, and PINCH, a FA pro-
tein that binds the NH
 
2
 
-terminal domain of ILK, form a
complex in cells. Using multiple approaches (epitope-
tagged CH-ILKBP, monoclonal anti–CH-ILKBP anti-
bodies, and green ﬂuorescent protein–CH-ILKBP), we
 
demonstrate that CH-ILKBP localizes to FAs and associ-
ates with the cytoskeleton. Deletion of the ILK-binding
CH2 domain abolished the ability of CH-ILKBP to local-
ize to FAs. Furthermore, the CH2 domain alone is sufﬁ-
cient for FA targeting, and a point mutation that inhibits
the ILK-binding impaired the FA localization of CH-
ILKBP. Thus, the CH2 domain, through its interaction
with ILK, mediates the FA localization of CH-ILKBP. Fi-
nally, we show that overexpression of the ILK-binding
CH2 fragment or the ILK-binding defective point mu-
tant inhibited cell adhesion and spreading. These ﬁnd-
ings reveal a novel CH-ILKBP–ILK–PINCH complex
and provide important evidence for a crucial role of this
complex in the regulation of cell adhesion and cytoskel-
eton organization.
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Introduction
 
Cell adhesion to the extracellular matrix (ECM)
 
1
 
 is medi-
ated primarily by integrins (Hynes, 1992), which together
with soluble factors, control gene expression, differentia-
tion, proliferation, and morphological changes (Clark and
Brugge, 1995; Schwartz et al., 1995; Dedhar and Hannigan,
1996; Sastry and Horwitz, 1996). Focal adhesions (FAs) are
integrin-rich cell adhesion sites through which the ECM is
physically linked to the actin cytoskeleton and signals are
transduced into the intracellular compartment (for review
see Jockusch et al., 1995; Burridge and Chrzanowska-Wod-
nicka, 1996; Calderwood et al., 2000). A selective group of
cytoplasmic proteins, which include catalytic proteins such
as FA kinase (FAK) and noncatalytic proteins such as
 
a
 
-actinin, talin, and paxillin are recruited to FAs in re-
sponse to cell adhesion (Parsons et al., 1994; Ilic et al.,
1997; Turner, 1998). Consistent with the fundamental roles
of cell matrix adhesions in control of cell behavior, many
components of the FAs are well conserved in different or-
ganisms ranging from nematodes and insects to verte-
brates (Hynes and Zhao, 2000).
Integrin-linked kinase (ILK) is an evolutionally con-
served FA protein that is involved in the integrin-mediated
processes (Hannigan et al., 1996; Dedhar et al., 1999; Li et
al., 1999; Wu, 1999). ILK participates in the regulation of
cell adhesion, growth, gene expression, differentiation, cell
shape change, and ECM assembly. Furthermore, recent
genetic studies in 
 
Caenorhabditis elegans
 
 [Mackinnon,
A.C., and B.D. Williams. 2000. 40th American Society for
Cell Biology Annual Meeting. 2664. (Abstr.)] and 
 
Dro-
sophila
 
 (Zervas et al., 2001) have demonstrated that lack
of ILK expression results in phenotypes resembling that of
integrin-null mutants, suggesting that ILK is indispensable
for integrin function during embryonic development.
Although it is clear that ILK is an important component
of FAs, how ILK functions in FA is not completely under-
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stood. At the molecular level, ILK consists of three struc-
turally distinct motifs. At the NH
 
2
 
 terminus of ILK lie four
ankyrin (ANK) repeats, which are responsible for binding
to PINCH (Tu et al., 1999). The PINCH binding is re-
quired for FA localization of ILK (Li et al., 1999). In addi-
tion, it connects ILK to other proteins including Nck-2, a
SH2/3-containing adaptor protein involved in the growth
factor and small GTPase signaling (Tu et al., 1998). The
importance of the ILK–PINCH interaction is underscored
by recent genetic studies in 
 
C. elegans
 
 (Hobert et al., 1999),
showing that lack of PINCH causes a phenotype that
is identical to that of null mutation of 
 
b
 
-integrin/
 
pat-3
 
or ILK/
 
pat-4
 
. COOH-terminal to the ANK repeat do-
main is a pleckstrin homology-like motif that likely binds
PtdIns(3,4,5)P3 and participates in the regulation of the ki-
nase activity (Delcommenne et al., 1998). ILK COOH-ter-
minal domain exhibits significant homology to other
kinase catalytic domains (Dedhar et al., 1999). ILK phos-
phorylates several key proteins including PKB/Akt and
glycogen synthase kinase 3 and regulates their activation
(Delcommenne et al., 1998). In addition to catalyzing
serine/threonine phosphorylation, the multidomain struc-
ture and FA localization of ILK suggest that it could po-
tentially function as a scaffolding protein mediating multi-
ple protein–protein interactions. To test this hypothesis,
we have carried out studies aimed at identifying additional
ILK-binding proteins. We report here the identification of
a new calponin homology (CH) domain-containing ILK-
binding protein (CH-ILKBP) that is widely expressed and
highly conserved among different organisms. Furthermore,
we have characterized the interaction between ILK and
CH-ILKBP and show that CH-ILKBP, ILK, and PINCH
form a complex in cells. Additionally, we demonstrate that
CH-ILKBP localizes to FAs and the ILK-binding activity
is required for the FA localization. Finally, we provide
functional evidence showing that CH-ILKBP is critically
involved in the regulation of cell adhesion and spreading.
 
Materials and Methods
 
Yeast Two-Hybrid Assays
 
A cDNA fragment encoding human ILK residues 136–452 was inserted
into the EcoRI/XhoI sites of a pLexA vector (CLONTECH Laboratories,
Inc.). The resulting construct (pLexA/ILK
 
136–452
 
) was used as a bait to
screen a human heart MATCHMAKER LexA cDNA library (
 
.
 
3 
 
3
 
 10
 
6
 
–
independent clones) (CLONTECH Laboratories, Inc.) as described (Tu et
al., 1998, 1999). 48 positive colonies were obtained and analyzed by PCR.
A majority (39 out of the 48) of them contain cDNA inserts with an identi-
cal size (1.5 kb). Four clones from this major positive group were selected,
and the cDNA inserts were sequenced. They contain an identical cDNA
fragment encoding CH-ILKBP residues 29–372. A cDNA encoding full-
length CH-ILKBP was isolated from a human heart cDNA library
(CLONTECH Laboratories, Inc.) by PCR using the following primers: 5
 
9
 
-
GGTCCATATGGCCACCTCCCCGCAGAAG-3
 
9
 
 and 5
 
9
 
-CTGCTC-
GAGTCACTCCACGTTACGGTAC-3
 
9
 
). Additionally, we performed
yeast two-hybrid binding assays to determine the interactions between spe-
cific CH-ILKBP and ILK sequences. The interactions were quantified by
measuring the 
 
b
 
-galactosidase activity as described (Tu et al., 1998, 1999).
 
Northern Blot
 
A 
 
32
 
P-labeled CH-ILKBP cDNA probe was prepared by labeling a human
CH-ILKBP cDNA fragment (encoding residues 1–229) using a random-
primed DNA labeling kit (Boehringer). A blot containing equal amount
(2 
 
m
 
g /lane) of polyA
 
1
 
 RNA from different human tissues (CLONTECH
 
Laboratories, Inc.) was hybridized with the 
 
32
 
P-labeled CH-ILKBP probe
following the manufacturer’s protocol.
 
Site-directed Mutagenesis
 
A QuickChange™ site-directed mutagenesis system (Stratagene) was
used to change F at position 271 to D. The point mutation was confirmed
by DNA sequencing.
 
Generation of Glutathione-S-Transferase– and Maltose-
binding Protein–CH-ILKBP Fusion Proteins
 
DNA fragments encoding CH-ILKBP sequences were prepared by PCR
and inserted into the EcoRI/XhoI sites of a pGEX-5x-1 vector (Amer-
sham Pharmacia Biotech) or the EcoRI/SalI sites of a pMAL-C2 vector
(New England BioLabs, Inc.). The recombinant vectors were used to
transform 
 
Escherichia coli
 
 cells. The expression of the glutathione 
 
S
 
-trans-
ferase (GST) and maltose-binding protein (MBP) fusion proteins was in-
duced with IPTG, and they were purified by affinity chromatography us-
ing glutathione-Sepharose 4B and amylose-agarose (Tu et al., 1999),
respectively.
 
GST Fusion Protein Pull-Down Assays
 
Mouse C2C12 cells were lysed with 1% Triton X-100 in 20 mM Tris HCl,
pH 7.5, 150 mM NaCl, 5 mM EDTA, 1 mM Na
 
3
 
VO
 
4
 
, 2 mM AEBSF, 5 
 
m
 
g/
ml pepstatin A, 10 
 
m
 
g/ml aprotinin, and 10 
 
m
 
g/ml leupeptin. The lysates
were precleared and then incubated with equal amounts of GST–CH-
ILKBP fusion proteins or GST for 2 h at 4
 
8
 
C. GST and GST fusion pro-
teins were precipitated with glutathione-Sepharose beads and ILK was
detected by Western blotting with anti-ILK antibody 65.1 (5 
 
m
 
g/ml).
 
Generation of Monoclonal Anti–CH-ILKBP Antibodies
 
Mouse monoclonal anti–CH-ILKBP antibodies were prepared using GST
fusion protein containing CH-ILKBP residues 29–372 as an antigen based
on a previously described method (Tu et al., 1998). Hybridoma superna-
tants were initially screened for anti–CH-ILKBP activities by ELISA and
Western blotting using MBP–CH-ILKBP
 
29–372
 
. Antibodies that recognize
MBP–CH-ILKBP
 
29–372
 
 were selected and further tested by Western blot-
ting using GST–CH-ILKBP fusion proteins and mammalian cell lysates.
 
Expression of FLAG– and Green Fluorescent Protein–
CH-ILKBP Fusion Proteins in Mammalian Cells
 
DNA fragments encoding CH-ILKBP sequences were cloned into the
EcoRI/KpnI sites of the p3XFLAG–CMV-14 vector (Sigma-Aldrich) or
those of the pEGFP-N1 vector (CLONTECH Laboratories, Inc.). C2C12
cells, rat mesangial cells, and CHO K1 cells were transfected with the vec-
tors using LipofectAmine PLUS (Life Technologies) (Huang et al., 2000).
 
Coimmunoprecipitation Assays
 
To immunoprecipitate endogenous CH-ILKBP, C2C12 cells were lysed
with 1% Triton X-100 in the Hepes buffer (50 mM Hepes, pH 7.1, 150 mM
NaCl, 10 mM Na
 
4
 
P
 
2
 
O
 
7
 
, 2 mM Na
 
3
 
VO
 
4
 
, 100 mM NaF, 10 mM EDTA) con-
taining protease inhibitors. The cell lysates (750 
 
m
 
g) were incubated with
750 
 
m
 
l of hybridoma culture supernatant containing anti–CH-ILKBP anti-
body 1D4 or 750 
 
m
 
l of unconditioned medium as a control for 2 h. The sam-
ples were then mixed with 50 
 
m
 
l of UltraLink immobilized protein G
(Pierce Chemical Co.). After incubation for 2 h, the beads were washed
four times, and the proteins bound were released from the beads by boiling
in 75 
 
m
 
l of SDS-PAGE sample buffer for 5 min. The samples (10 
 
m
 
l/lane)
were analyzed by Western blotting with anti–CH-ILKBP antibody 3B5,
anti-ILK antibody 65.1, antipaxillin antibody (clone 349; Transduction
Laboratories), and rabbit polyclonal anti-PINCH antibodies, respectively.
To immunoprecipitate FLAG-tagged, wild-type, or mutant forms of
CH-ILKBP, lysates (prepared as described above) of the C2C12 transfec-
tants (500 
 
m
 
g lysates) or the CHO transfectants (750 
 
m
 
g lysates) were
mixed with 70 
 
m
 
l agarose beads conjugated with anti-FLAG antibody M2
(Sigma-Aldrich). The precipitated proteins were released from the beads
by boiling in 50 
 
m
 
l of SDS-PAGE sample buffer for 5 min and analyzed by
Western blotting (10 
 
m
 
l/lane).
To immunoprecipitate FLAG-PINCH, C2C12 cells were transfected
with pFLAG–CMV-2/PINCH, which was generated by inserting the full-
length PINCH cDNA into the BglII/SalI sites of the pFLAG–CMV-2 vec- 
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tor (Sigma-Aldrich) using LipofectAmine2000 (Life Technologies). 24 h
after transfection, the cells were lysed with 1% Triton X-100 in 50 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM Na
 
3
 
VO
 
4
 
, and 100 mM NaF con-
taining protease inhibitors. The lysates (1 mg) were mixed with 30 
 
m
 
l aga-
rose beads conjugated with anti-FLAG antibody M2. The precipitated
proteins were released from the beads by boiling in 60 
 
m
 
l of SDS-PAGE
sample buffer for 5 min and analyzed by Western blotting (10 
 
m
 
l/lane).
To immunoprecipitate paxillin, C2C12 lysates (500 
 
m
 
g) were mixed
with 2 
 
m
 
g of antipaxillin antibody or 2 
 
m
 
g of irrelevant mouse IgG. The
immune complexes were precipitated with 50 
 
m
 
l of UltraLink immobilized
protein G, and the proteins bound were released from the beads by boil-
ing in 50 
 
m
 
l of SDS-PAGE sample buffer for 5 min. The samples (10 
 
m
 
l/
lane) were analyzed by Western blotting.
 
Immunofluorescence Staining of Cells
 
Immunofluorescence staining was performed as described (Li et al., 1999).
In brief, cells were plated on fibronectin-coated coverslips, fixed, and
stained with mouse anti–CH-ILKBP antibody 1D4 (hybridoma superna-
tant), mouse anti-FLAG antibody M2 (4 
 
m
 
g/ml), rabbit anti-FAK anti-
body (4 
 
m
 
g/ml) (Santa Cruz Biotechnology, Inc.), and/or rabbit anti–
 
b
 
-catenin antiserum (1:2,000 dilution) (Sigma-Aldrich). The mouse and
rabbit antibodies were detected with a fluorescein-conjugated anti–mouse
IgG antibody (28 
 
m
 
g/ml) and a Rhodamine red
 
TX
 
-conjugated anti–rabbit
IgG antibody (10 
 
m
 
g/ml), respectively. In control experiment, no specific
staining was observed with unconditioned medium or with ID4 superna-
tants that were preincubated with 1 
 
m
 
M GST–CH-ILKBP for 1 h. For
staining of cells expressing green fluorescent protein (GFP)–CH-ILKBP
fusion proteins, anti-ILK and FAK antibodies were detected with
Rhodamine red
 
TX
 
-conjugated anti–mouse and anti–rabbit IgG antibodies,
respectively. Actin stress fibers were visualized by staining the cells with
rhodamine-labeled phalloidin.
 
Isolation of Cytoskeleton Fractions
 
Cytoskeleton fractions were isolated from C2C12 cells as described (Yang
et al., 1994). In brief, C2C12 cell monalayers were extracted with 0.7 ml of
cold PBS containing 1% Trion X-100 and protease inhibitors. The Triton
X-100–insoluble material (cytoskeletal fractions) remaining on the dishes
was extracted with equal volume (0.7 ml) of PBS containing 1% SDS and
protease inhibitors. The distributions of CH-ILKBP and other FA pro-
teins were analyzed by Western blotting (30 
 
m
 
l/lane).
 
Cell Adhesion and Spreading Assays
 
For assays using CHO cells, the cells were transfected with FLAG vectors
encoding CH-ILKBP, CH2 (residues 222–372), CH-ILKBP F271
 
®
 
D
point mutant, CH2 deletion mutant (residues 1–229), or a FLAG vector
lacking CH-ILKBP sequence using LipofectAmine PLUS. Cell adhesion
assays were performed as described (Wu et al., 1995). In brief, the trans-
fectants were harvested with trypsin 1 d after transfection and washed
twice with 
 
a
 
-MEM containing 10% FBS, twice with serum-free Opti-
MEM (Life Technologies), and kept in suspension for 30 min. The cells
(3 
 
3
 
 10
 
4
 
/well) were seeded in collage IV–coated 96-well plates (Becton
Dickinson). After incubation at 37
 
8
 
C under a 5% CO
 
2
 
–95% air atmo-
sphere for 90 min, the wells were washed three times with PBS. The num-
bers of adhered cells were quantified by measuring 
 
N
 
-acetyl-
 
b
 
-
 
D
 
-hex-
osaminidase activity (Landegren, 1984).
For assays using C2C12 cells, the cells were transfected with FLAG
vectors encoding CH-ILKBP (FLAG–CH-ILKBP), CH2 (residues 222–
372) (FLAG-CH2), CH2 deletion mutant (residues 1–229) (FLAG-
 
D
 
CH2), or a FLAG control vector using LipofectAmine PLUS. C2C12
cells stably expressing the FLAG-tagged proteins were selected with 1 mg/
ml of G418 (Life Technologies). Two independent clones expressing each
form of CH-ILKBP were isolated. C2C12 cells expressing FLAG-
CHILKBP (clones A28 and A31), FLAG-CH2 (clones B20 and B45),
FLAG-
 
D
 
CH2 (clones C31 and C46), and the vector control cells were har-
vested with trypsin. The cells were washed twice with DME containing
10% FBS and twice with DME containing 1% BSA. The cells were kept
in suspension for 30 min and then seeded in 12-well plates coated with col-
lagen I (Becton Dickinson). The cells were allowed to adhere at 37
 
8
 
C for
30 min, and four randomly selected fields were photographed. The plates
were then washed twice with PBS, and four randomly selected fields were
photographed after the wash. The numbers of the total cells (before wash)
and the adhered cells (after wash) from the four randomly selected fields
were counted manually. The percentage of cell adhesion is presented as
 
the number of adhered cells divided by the number of total cells. In addi-
tion to manual counting, we also measured cell adhesion using the hex-
osaminidase method and obtained similar results.
For cell spreading, C2C12 cells expressing different forms of CH-
ILKBP were prepared as described above and seeded in 12-well plates
coated with collagen I. The plates were incubated at 37
 
8
 
C under a 5%
CO
 
2
 
-95% air atmosphere for different periods of time. The cell mor-
phology (phase–contrast image) was recorded with a DVC-1310C
Magnafire™ digital camera (Optronics). Unspread cells were defined as
round phase–bright cells, whereas spread cells were defined as cells with
extended processes, lacking a rounded morphology and not phase–bright
(Komoriya et al., 1991; Richardson et al., 1997). The percentage of cells
adopting spread morphology was quantified by analyzing 
 
$
 
300 cells from
three randomly selected fields (
 
.
 
100 cells/field).
 
Online Supplemental Material
 
Figure S1: Association of FLAG–CH-ILKBP, FLAG-F271D, and FLAG-
 
D
 
CH2 with Triton X-100–insoluble cytoskeleton fractions. Figure S2: CH-
ILKBP binds to ILK but not paxillin in rat embryo fibroblasts (REF-52).
Figure S3: Immunofluorescence staining of GFP–CH-ILKBP–expressing
cells with monoclonal antipaxillin antibody. Supplemental figures avail-
able at http://www.jcb.org/cgi/content/full/153/3/585/DC1.
 
Results
 
Identification of a Novel ILK-binding Protein 
by Yeast Two-Hybrid Screens
 
To identify proteins that interact with the COOH-terminal
region of ILK, we screened a human heart LexA cDNA li-
brary with a bait construct encoding ILK residues 136–452.
48 positive clones were obtained. PCR analyses showed
that 39 out of the 48 positive clones contained cDNA in-
serts with an identical size (1.5 kb). Four clones (clones 10,
12, 35, and 36) from this major positive group were selected
and sequenced. The results showed that they contained an
identical cDNA insert. BLAST searches of cDNA data-
base revealed that this insert overlaps with several EST
clones and a cDNA encoding an “Unnamed Protein Prod-
uct” (sequence data available from Genbank/EMBL/
DDBJ under accession numbers AA057458, AA316121,
and AK001655). A cDNA encoding the full-length ILKBP
was isolated from the heart cDNA library by PCR. It en-
codes a protein of 372 residues comprising two CH do-
mains at the COOH-terminal region (Fig. 1 A) and was
therefore designated as CH domain–containing ILK-bind-
ing protein or CH-ILKBP. The CH domains of CH-ILKBP
share significant homology with those of 
 
a
 
-actinin, filamin,
and other actin-binding proteins. Proteins that are structur-
ally closely related are present in other organisms including
 
C. elegans
 
 (Fig. 1 A), suggesting that CH-ILKBP, like ILK
and PINCH, represents an ancient protein.
Northern blot analyses with a 
 
32
 
P-labeled CH-ILKBP
cDNA probe showed three positive bands (4.4, 3.5, and 1.7
kb) in almost all human tissues tested, with strong signals
detected in the heart, skeletal muscle, and kidney (Fig. 1
B). Additional bands, which likely represent tissue-spe-
cific CH-ILKBP isoforms or other related transcripts,
were also detected in the heart and the skeletal muscle.
The presence of multiple bands suggests that there likely
exists a family of structurally related proteins. To confirm
the interaction between ILK and CH-ILKBP, we cotrans-
formed yeast cells with purified ILK and CH-ILKBP ex-
pression vectors and found that they readily bind to each
other (Table I). In control experiments, replacement of ei- 
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Figure 1. Identification of a new CH-containing ILK-binding pro-
tein. (A) Sequence alignment of human CH-ILKBP (sequence
data available from GenBank/EMBL/DDBJ under accession
number AF325830) with C. elegans T21D12.4 protein (sequence
data available from GenBank/EMBL/DDBJ under accession no.
AAC48090). Identical residues are indicated by gray back-
ground. The CH domains are underlined. (B) Northern blotting.
Two micrograms of polyA1 RNA from human tissues were hy-
bridized with a CH-ILKBP cDNA probe as described in Materi-
als and Methods. Arrowheads indicate the positions of three
transcripts (4.4, 3.5, and 1.7 kb). (C) ILK residues involved in the
CH-ILKBP binding. The binding was determined by yeast two-
hybrid binding assays as described in Materials and Methods.
The numbers in parentheses indicate ILK, CH-ILKBP, and
PINCH residues.
 
ther binding partner sequence with those of other proteins
(for example, PINCH and lamin C) abolished the binding
(Table I), confirming the specificity of the assay.
 
The ILK COOH-terminal Domain but not
the NH
 
2
 
-terminal Domain Mediates the 
Interaction with CH-ILKBP
 
We next sought to identify regions of ILK involved in the
CH-ILKBP binding. To do this, we expressed the full-
length and various ILK mutants in yeast cells and analyzed
the CH-ILKBP–binding activities (Fig. 1 C). The full-
length ILK, like the ILK COOH-terminal fragment (136–
452), readily binds to CH-ILKBP (Fig. 1 C). By contrast,
the NH
 
2
 
-terminal ANK domain (1–163), which binds
PINCH (Fig. 1 C) (Tu et al., 1999), failed to bind to
CH-ILKBP. Furthermore, no interaction between an ILK
mutant (residues 136–324) containing the pleckstrin ho-
mology-like motif but lacking the COOH-terminal most
residues was detected (Fig. 1 C), suggesting that the
COOH-terminal most residues are required for the bind-
ing. However, the COOH-terminal most residues are not
sufficient for the binding, since an ILK mutant containing
residues 193–452 failed to bind CH-ILKBP (Fig. 1 C).
Taken together, these results suggest that the COOH-ter-
minal domain of ILK is both necessary and sufficient for
the interaction with CH-ILKBP.
 
The CH2 Domain Mediates the Interaction with ILK
 
To confirm the interaction between CH-ILKBP and ILK,
we generated GST fusion proteins containing the full-
length (Fig. 2 A, lane 1) and the COOH-terminal region
(
 
D
 
N-ter, residues 29–372) (Fig. 2 A, lane 7) of CH-ILKBP
and tested their ability to bind ILK. Both GST–CH-ILKBP
(Fig. 2 B, lane 1) and GST–
 
D
 
N-ter (29–372) (Fig. 2 B, lane
7), but not GST alone (Fig. 2 B, lane 8), interacted with
ILK. These results are consistent with those obtained in the
yeast two-hybrid binding assays and confirm that CH-ILKBP
forms a complex with ILK in vitro and in yeast cells.
CH-ILKBP contains two tandem CH domains (Fig. 1
A). To define the ILK-binding site on CH-ILKBP, we
generated a series of GST fusion proteins containing dif-
ferent regions of CH-ILKBP (Fig. 2 A) and analyzed their
ILK-binding activities. Deletion of 221 residues from the
NH
 
2
 
 terminus did not reduce the ILK-binding activity
(Fig. 2 B, lane 2), indicating that the NH
 
2
 
-terminal region
including CH1 is not required for the ILK binding. Fur- 
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thermore, a GST fusion protein containing only the CH2
domain bound to ILK (Fig. 2 B, lane 4). By contrast, dele-
tion of either the entire or part of CH2 abolished the ILK
binding (Fig. 2 B, lanes 3, 5, and 6). We conclude from
these results that the CH2 domain mediates the interac-
tion with ILK.
 
CH-ILKBP Associates with ILK in Mammalian Cells
 
To facilitate studies on CH-ILKBP in mammalian cells, we
generated mouse monoclonal anti–CH-ILKBP antibodies.
Two antibodies (1D4 and 3B5), which recognize GST–
CH-ILKBP (Fig. 3, A and B, lane 2) and MBP–CH-
ILKBP
 
29–372
 
 (data not shown) but not GST (Fig. 3, A and
B, lane 1), were further characterized. 1D4 recognizes an
epitope located within the link region between the two CH
domains of CH-ILKBP (Fig. 3 A), whereas 3B5 recognizes
an epitope located within the NH
 
2
 
-terminal region (resi-
dues 1–229) (Fig. 3 B). To test whether ILK interacts with
CH-ILKBP in mammalian cells, we immunoprecipitated
CH-ILKBP from C2C12 cell lysates with anti–CH-ILKBP
antibody 1D4. Western blotting analyses showed that ILK
(Fig. 3 C, lane 2) was coprecipitated with CH-ILKBP (Fig.
3 D, lane 2). Probing the same samples with an antipaxillin
antibody failed to detect paxillin in the anti–CH-ILKBP
immunoprecipitates (Fig. 3 E, lane 2), despite the presence
of abundant paxillin in the cell lysate (Fig. 3 E, lane 1). In
additional control experiments, neither CH-ILKBP nor
ILK was precipitated in the absence of the anti–CH-ILKBP
antibody (Fig. 3, C and D, lane 4). Thus, consistent with
the ILK–CH-ILKBP interaction detected in yeast cells
and in vitro, ILK and CH-ILKBP form a complex in mam-
malian cells.
 
CH-ILKBP, ILK, and PINCH Form a Ternary 
Complex in Mammalian Cells
 
We next tested whether the CH-ILKBP–ILK complex as-
sociates with PINCH, an FA protein that interacts with the
NH
 
2
 
-terminal ANK domain of ILK (Tu et al., 1999). West-
ern blotting analyses of the anti–CH-ILKBP immunopre-
cipitates with anti-PINCH antibodies showed that PINCH
(Fig. 3 F, lane 2) was coprecipitated with ILK (Fig. 3 C,
lane 2) and CH-ILKBP (Fig. 3 D, lane 2). These results
suggest that CH-ILKBP, ILK, and PINCH form a com-
plex in mammalian cells. To confirm this, we expressed
FLAG-PINCH in C2C12 cells (Fig. 4 A, lane 1). FLAG-
PINCH was immunoprecipitated from the cell lysates with
anti-FLAG antibody (Fig. 4 A, lane 3). Western blotting
analyses of the immunoprecipitates showed that, as ex-
pected, ILK (Fig. 4 B, lane 3) was coimmunoprecipitated
with FLAG-PINCH (Fig. 4 A, lane 3). Consistent with
coimmunoprecipitation of PINCH with ILK and CH-
ILKBP (Fig. 3, C, D, and F), CH-ILKBP was coprecipi-
tated with ILK and FLAG-PINCH (Fig. 4 C, lane 3). In
control experiments, neither ILK (Fig. 4 B, lane 4) nor
CH-ILKBP (Fig. 4 C, lane 4) was precipitated with the
anti-FLAG antibody in the absence of FLAG-PINCH
(Fig. 4 A, lane 4), confirming the specificity of the assays.
In additional control experiments, we immunoprecipitated
paxillin and found that CH-ILKBP was not coprecipitated
with paxillin (Fig. 4, D and E). Taken together, these re-
sults show that CH-ILKBP forms a complex with ILK and
PINCH but not with paxillin in mammalian cells.
 
Table I. The ILK COOH-terminal Domain Specifically 
Interacts with CH-ILKBP in Yeast
 
pLexA construct pB42AD construct Reporter gene
 
LEU2 lacZ
 
pLexA-ILK
 
136–452
 
pB42AD–CH-ILKBP
 
29–372
 
11
 
pLexA-Lam C pB42AD–CH-ILKBP
 
29–372
 
22
 
pLexA-ILK
 
136–452
 
pB42AD-PINCH
 
22
 
The interactions between the proteins encoded by the pLexA and pB42AD constructs
were determined by yeast two-hybrid assays as described in Materials and Methods.
Figure 2. The CH2 domain mediates the interaction with ILK.
(A) GST–CH-ILKBP fusion proteins were separated on SDS-
PAGE (10 mg/lane) and detected by Coomassie blue R-250 stain-
ing. The numbers in parentheses indicate CH-ILKBP residues.
(B) ILK binding. C2C12 cell lysates (100 mg) were incubated with
equal amount (10 mg) of GST or GST fusion proteins containing
CH-ILKBP sequences as indicated in the figure. GST and the
GST fusion proteins were precipitated with glutathione-
Sepharose 4B beads. ILK was detected by Western blotting with
anti-ILK antibody 65.1. (Lane 9) C2C12 cell lysates (10 mg/lane).The Journal of Cell Biology, Volume 153, 2001 590
Figure 3. CH-ILKBP forms a complex with ILK
and PINCH in mammalian cells. (A and B) GST
and GST–CH-ILKBP proteins (0.1 mg protein/lane)
were analyzed by Western blotting with anti–CH-
ILKBP antibody 1D4 (A) and 3B5 (B). (C and D)
Coimmunoprecipitation of ILK with CH-ILKBP.
Anti–CH-ILKBP immunoprecipitates (lane 2) and
control precipitates (lane 4) were prepared using
C2C12 cell lysates as described in Materials and
Methods. ILK and CH-ILKBP were detected by
Western blotting with anti-ILK antibody 65.1 (C)
and anti–CH-ILKBP antibody 3B5 (D), respec-
tively. Lane 1 was loaded with C2C12 cell lysates
(20 mg protein/lane). (E and F) Cell lysates (lane 1)
and anti–CH-ILKBP immunoprecipitates (lane 2)
were analyzed by Western blotting using mouse an-
tipaxillin (E) or rabbit anti-PINCH (F) antibodies.
Lane 3 was loaded with samples prepared like those
of lane 2 except that the lysates were omitted.
Figure 4. Coimmunoprecipitation of CH-
ILKBP and ILK with FLAG-PINCH. (A and
B) FLAG-PINCH was immunoprecipitated
from lysates of C2C12 cells expressing
FLAG-PINCH. FLAG-PINCH immunopre-
cipitates (lane 3) or control precipitates (lane
4) were analyzed by Western blotting with anti-
FLAG antibody M2 (A), anti-ILK antibody
65.1 (B), or anti–CH-ILKBP antibody 3B5 (C).
Lanes 1 and 2 were loaded with lysates (7.5 mg
protein/lane) of the FLAG-PINCH–expressing
C2C12 cells and the control C2C12 cells, re-
spectively. (D and E) Antipaxillin immunopre-
cipitates (lane 2) or control IgG precipitates
(lane 3) were blotted with antipaxillin anti-
body (D) or anti–CH-ILKBP antibody 3B5
(E). (Lane 1) 10 mg lysates; (lane 4) 0.4 mg an-
tipaxillin IgG.Tu et al. A New ILK-binding Protein 591
Figure 5. Complex formation and subcellular localization of
FLAG–CH-ILKBP. (A–D) Coimmunoprecipitation of ILK and
PINCH with FLAG–CH-ILKBP. The FLAG–CH-ILKBP immu-
noprecipitates (lane 3) and control precipitates (lane 4) were pre-
pared as described in Materials and Methods and analyzed by
Western blotting with anti-FLAG antibody M2 (A), anti-ILK an-
tibody 65.1 (B), and antipaxillin antibody (clone 349) (C), respec-
tively. Lanes 1 and 2 were loaded with cell lysates (20 mg protein/
lane). In D, the membrane used in C was reprobed (without
striping) with anti-PINCH antibodies. (E–J) FA localization of
FLAG–CH-ILKBP. Rat mesangial cells were transfected with
the FLAG–CH-ILKBP vector (E–H) or a FLAG vector as a con-
trol (I and J). The FLAG–CH-ILKBP, FAK, and actin stress fi-
bers were detected by staining the cells with mouse anti-FLAG
antibody M2 (E, G, and I), rabbit anti-FAK antibody (F), or
rhodamine-labeled phalloidin (H and J). We also analyzed the
subcellular localization of FLAG–CH-ILKBP in C2C12 cells and
obtained similar results (not shown). Bar, 5 mm.The Journal of Cell Biology, Volume 153, 2001 592
CH-ILKBP Localizes to FAs and Associates 
with the Cytoskeleton
Previous studies have shown that ILK is a component of
FAs (Hannigan et al., 1996; Li et al., 1999), sites where ac-
tin cytoskeleton connects to integrins and the ECM. The
finding that CH-ILKBP binds to ILK prompted us to ex-
amine whether CH-ILKBP localizes to FAs. To do this,
we expressed FLAG–CH-ILKBP in mammalian cells. We
first analyzed the ability of FLAG–CH-ILKBP to interact
with ILK by coimmunoprecipitation assays. The results
showed that ILK (Fig. 5 B, lane 3) was coimmunoprecipi-
tated with FLAG–CH-ILKBP (Fig. 5 A, lane 3). Analyses
of the same immunoprecipitates showed that paxillin was
not coimmunoprecipitated with FLAG–CH-ILKBP (Fig.
5 C, lane 3). Reprobing the membrane with anti-PINCH
antibodies showed that, as expected, PINCH was coimmu-
noprecipitated with ILK and FLAG–CH-ILKBP (Fig. 5
D, lane 3). In control experiments, neither ILK (Fig. 5 B,
lane 4) nor PINCH (Fig. 5 C, lane 4) was precipitated in
the absence of FLAG–CH-ILKBP (Fig. 5 A, lane 4). Thus,
FLAG–CH-ILKBP like endogenous CH-ILKBP forms a
complex with ILK and PINCH in mammalian cells.
To test whether FLAG–CH-ILKBP localizes to FAs, we
stained C2C12 cells and rat mesangial cells that express
FLAG–CH-ILKBP with anti-FLAG antibodies. The re-
sults showed that FLAG–CH-ILKBP is targeted to FAs
(Fig. 5 E), where clusters of FAK (a marker of FAs) were
also detected (Fig. 5 F). Clusters of FLAG–CH-ILKBP
were concentrated at the ends of actin stress fibers (Fig. 5,
G and H). In control experiments, no specific staining was
observed in cells transfected with a control FLAG vector
(Fig. 5, I and J), confirming the specificity of the staining.
In additional experiments, we expressed GFP–CH-ILKBP
in mammalian cells and found that it also localized to FAs
(see below).
To analyze the subcellular localization of endogenous
CH-ILKBP, we stained mammalian cells with monoclonal
anti–CH-ILKBP antibodies. The results showed that en-
dogenous CH-ILKBP (Fig. 6 A) like FLAG–CH-ILKBP
(Fig. 5, E and G) was clustered in FAs where FAKs were
also detected (Fig. 6 B). Clusters of CH-ILKBP were con-
centrated at the ends of actin stress fibers (Fig. 6, C and
D). In epithelial cells that had formed cell–cell contacts,
CH-ILKBP localized to cell matrix FAs but not to cell–
cell adhesions where abundant b-catenin was detected
(Fig. 6, E and F). In control experiments, incubation of
the anti–CH-ILKBP antibody with GST–CH-ILKBP
eliminated the staining (data not shown), confirming the
specificity of the antibody staining. The observation that
CH-ILKBP is concentrated at the ends of actin stress fi-
bers suggested a possibility that CH-ILKBP is physically
associated with the cytoskeleton fractions. To test this, we
isolated cytoskeleton fractions from C2C12 cells. Under
the conditions used, z5–10% of CH-ILKBP was found in
the Triton X-100–insoluble cytoskeleton fractions (Fig. 6
G). As a comparison, we found that a similar percentage
of FAK (Fig. 6 H), an abundant component of FAs, and
no detectable amount of extracellular signal–regulated ki-
nase (ERK) (Fig. 6 I), a more dynamic component of FAs
(Fincham et al., 2000), was present in the cytoskeleton
fractions.
The FA Localization of CH-ILKBP Is Mediated
by the ILK-binding CH2 Domain
We next sought to determine the domain of CH-ILKBP
that mediates the FA localization of CH-ILKBP. To do
this, we expressed GFP fusion proteins containing the full-
length CH-ILKBP (GFP–CH-ILKBP), the CH2 deletion
Figure 6. FA localization and cytoskeleton association of CH-
ILKBP. (A–F) Subcellular localization of CH-ILKBP. Primary
rat mesangial cells were stained with mouse anti–CH-ILKBP an-
tibody 1D4 and rabbit anti-FAK antibodies (A and B) or anti–
CH-ILKBP antibody 1D4 and phalloidin (C and D). We have
also stained IEC18 rat intestinal epithelial cells, CHO cells, and
mouse C2C12 cells with anti–CH-ILKBP antibodies and found
that CH-ILKBP localizes to FA in these cells as well. Immunoflu-
orescence images of IEC18 cells stained with mouse anti–CH-
ILKBP antibody 1D4 (E) and rabbit anti–b-catenin antibody (F).
(G–I) Association of CH-ILKBP with Triton X-100–insoluble
cytoskeleton fractions. CH-ILKBP, FAK, and p44/42 ERK in
the Triton X-100–soluble and –insoluble fractions were detected
by Western blotting with anti–CH-ILKBP antibody 3B5 (G),
anti-FAK antibody (H), and anti-p44/42 ERK antibody (New
England Biolabs, Inc.) (I), respectively. Bar, 5 mm.Tu et al. A New ILK-binding Protein 593
mutant (GFP-DCH2), and the CH2 fragment (GFP-CH2)
in mammalian cells. Consistent with the results obtained
with anti–CH-ILKBP antibody (Fig. 6) and FLAG–CH-
ILKBP (Fig. 5), GFP–CH-ILKBP localized to FAs where
ILK (Fig. 7, A and B) and FAK (data not shown) were
clustered. Deletion of the ILK-binding CH2 domain elimi-
nated its ability to localize to FAs (Fig. 7, C and D), indi-
cating that the ILK-binding CH2 domain is required for
the FA localization. Furthermore, GFP fusion protein
containing the CH2 fragment was able to cocluster with
ILK in FAs (Fig. 7, E and F), albeit the level of fluores-
cence was lower than that of GFP–CH-ILKBP (Fig. 7,
compare A and E). Taken together, these results suggest
that the ILK-binding CH2 domain mediates the FA local-
ization of CH-ILKBP.
A Point Mutation That Disrupts the ILK-binding 
Impairs the FA Localization of CH-ILKBP
To further analyze the ILK-binding activity and FA local-
ization of CH-ILKBP, we introduced a point mutation
(F271D) into the ILK-binding CH2 domain of CH-ILKBP.
GST–CH-ILKBP fusion proteins bearing the F271D point
mutation were generated (Fig. 8 A), and their ILK-binding
activities were determined (Fig. 8 B). Neither the full-
length CH-ILKBP containing the F271D point mutation
(Fig. 8 B, lane 6) nor the CH2 domain containing the
F271D point mutation (Fig. 8 B, lane 2) bound to ILK. In
control experiments, both GST–CH-ILKBP (Fig. 8 B, lane
5) and the GST fusion protein containing the CH2 fragment
(Fig. 8 B, lane 3), but not GST alone (Fig. 8 B, lane 4),
bound to ILK. These results indicate that the F271D point
mutation ablated the ILK-binding activity. We next deter-
mined the effect of disrupting the ILK-binding on FA local-
ization of CH-ILKBP. To do this, we expressed a GFP–
CH-ILKBP protein bearing the F271D point mutation
(GFP-F271D) in mammalian cells. In contrast to GFP–CH-
ILKBP, which was coclustered with ILK in FAs (Fig. 7, A
and B), GFP-F271D was unable to localize to FAs where
abundant ILK was detected (Fig. 8, C and D). Thus, abla-
tion of the ILK-binding activity by a single amino acid sub-
stitution impairs the FA localization of CH-ILKBP.
CH-ILKBP Is Involved in the Regulation of Cell 
Adhesion and Spreading
The findings that CH-ILKBP interacts with ILK and local-
izes to FAs prompted us to investigate whether CH-ILKBP
plays a role in cell adhesion. To do this, we trans-
fected CHO cells with FLAG vectors encoding the full-
length CH-ILKBP, the ILK-binding defective F271D
point mutant, the ILK-binding CH2 fragment, the CH2
deletion mutant, or a FLAG vector lacking CH-ILKBP se-
quence as a control (Fig. 9 A). As expected, the FLAG-
tagged CH-ILKBP (Fig. 9 A, lane 2) and CH2 domain
(lane 4), but neither FLAG-F271D (lane 3) nor FLAG-
DCH2 (lane 5), formed a complex with ILK (Fig. 9 B) and
PINCH (Fig. 9 D) in CHO cells. Consistent with the re-
Figure 7. The ILK-binding CH2 domain mediates
the localization of CH-ILKBP to FAs. Rat mesangial
cells expressing GFP–CH-ILKBP (A and B), GFP-
DCH2 (residues 1–229) (C and D), or GFP-CH2
(residues 222–372) (E and F) were plated on fi-
bronectin-coated coverslips and stained with mouse
anti-ILK antibody 65.1 and Rhodamine redTX-conju-
gated anti–mouse IgG antibody. GFP fusion proteins
(A, C, and E) and ILK (B, D, and F) were visualized
under a fluorescence microscope equipped with
GFP and rhodamine filters. We have also expressed
GFP–CH-ILKBP, GFP-DCH2, and GFP-CH2 in
C2C12 cells and found that GFP–CH-ILKBP and
GFP-CH2 but not GFP-DCH2 localized to FAs in
these cells as well (not shown). Bar, 5 mm.The Journal of Cell Biology, Volume 153, 2001 594
sults obtained with C2C12 cells (Fig. 3 E and Fig. 5 C),
paxillin was not associated with the FLAG-tagged wild-
type or mutant forms of CH-ILKBP in CHO cells (Fig. 9
C, lanes 2–5), despite the presence of abundant paxillin in
these cells (Fig. 9 C, lanes 6–9). To analyze the effect of
overexpression of the different forms of CH-ILKBP on
cell adhesion, we plated the CHO cells on collagen IV–
coated 96-well plates and quantified the number of ad-
hered cells. The results showed that overexpression of
FLAG–CH-ILKBP did not significantly alter cell adhe-
sion (Fig. 9 E). However, overexpression of the ILK-bind-
ing defective CH-ILKBP point mutant F271D or the ILK-
binding CH2 fragment, but not that of the NH2-terminal
fragment lacking CH2, significantly reduced cell adhesion
(Fig. 9 E), suggesting that CH-ILKBP, through interac-
tions with ILK and other proteins, plays an important role
in the regulation of cell adhesion.
To confirm that CH-ILKBP is involved in cell adhesion,
we expressed FLAG-tagged CH-ILKBP, the ILK-binding
CH2 fragment, and the CH2 deletion mutant, respectively,
in a different cell type (C2C12 cells). Because of the rela-
tive low efficiency of transient transfection in C2C12 cells,
we isolated C2C12 clones stably expressing different forms
of CH-ILKBP. Two independent clones were isolated
from each transfection, and the expression of FLAG–CH-
ILKBP, FLAG-CH2, or FLAG-DCH2 in these cells was
confirmed by Western blotting (Fig. 10 A). Analyses of
the cell adhesion showed that although C2C12 cells over-
expressing CH-ILKBP adhered to collagen I as efficiently
as the vector control cells, C2C12 cells overexpressing the
ILK-binding CH2 fragment adhered much less efficiently
(Fig. 10 B). By contrast, overexpression of the CH2 dele-
tion NH2-terminal fragment did not significantly alter the
efficiency of cell adhesion (Fig. 10 B). Noticeably, the
spreading of the C2C12 cells overexpressing the ILK-bind-
ing CH2 fragment was much slower than that of the vector
control cells or those overexpressing FLAG–CH-ILKBP
or FLAG-DCH2 (Fig. 10, C and D). Staining of the CH2-
overexpressing cells with phalloidin reveled that the actin
stress fiber formation was retarded (Fig. 10 E). Thus, con-
sistent with the ILK-binding activity and FA localization
of CH-ILKBP, CH-ILKBP is critically involved in the reg-
ulation of cell adhesion, actin cytoskeleton organization,
and cell shape change.
Discussion
Cell matrix adhesion is a fundamental process that regu-
lates gene expression, differentiation, proliferation, and
morphological changes. FAs are important cell adhesion
sites through which the ECM is physically linked to the ac-
tin cytoskeleton (for reviews see Jockusch et al., 1995;
Burridge and Chrzanowska-Wodnicka, 1996; Calderwood
et al., 2000). In this study, we have identified a novel FA
protein (CH-ILKBP) that specifically interacts with ILK,
an important regulator of integrin-mediated processes
(Hannigan et al., 1996; Wu et al., 1998; Dedhar et al., 1999;
Wu, 1999). The interaction of ILK with CH-ILKBP is me-
diated by the COOH-terminal domain of ILK. In previous
studies, we have shown that ILK binds to PINCH through
ILK NH2-terminal ANK domain (Tu et al., 1999). Using
multiple experimental approaches, we show in this study
that PINCH, ILK, and CH-ILKBP form a ternary com-
plex in cells. CH-ILKBP localizes to FAs in response to
cell matrix but not cell–cell adhesions, a property shared
by ILK (Li et al., 1999). ILK likely plays a major role in re-
cruiting CH-ILKBP to FAs, as ILK is the only FA protein
that is known to bind to CH-ILKBP. Furthermore, the
ILK-binding CH2 domain, which does not bind to paxillin
in cells (Fig. 9), is both necessary and sufficient for the FA
targeting. Finally, a point mutation that disrupts the ILK
binding abolished the FA localization of CH-ILKBP.
These data suggest a model by which ILK functions in cell
adhesions. In this model, ILK, through its COOH- and
NH2-terminal domains, binds to CH-ILKBP and PINCH
Figure 8. A point mutation that disrupts the ILK binding impairs
the FA localization of CH-ILKBP. (A) GST–CH-ILKBP pro-
teins. GST fusion proteins containing the mutant form (F271D)
of CH2 domain (residues 258–372) (lane 1), the CH2 domain
(residues 258–372) (lane 2), CH-ILKBP (lane 4), and the F271D
point mutant (lane 5) and GST (lane 3) were separated on SDS-
PAGE (10 mg/lane) and detected by Coomassie blue R-250 stain-
ing. (B) ILK binding. C2C12 cell lysates (260 mg) were incubated
and precipitated with equal amount (10 mg) of GST or GST–CH-
ILKBP proteins as indicated. ILK was detected by Western blot-
ting with anti-ILK antibody 65.1. Lane 1 was loaded with C2C12
cell lysates (9 mg/lane). (C and D) FA localization. Rat mesangial
cells expressing GFP fusion protein containing the full-length
F271D point mutant were plated on fibronectin-coated coverslips
and stained with anti-ILK antibody 65.1 and Rhodamine red™-
conjugated anti–mouse IgG antibody. GFP-F271D (C) and ILK
(D) were visualized under a fluorescence microscope equipped
with GFP and rhodamine filters. Bar, 5 mm.Tu et al. A New ILK-binding Protein 595
simultaneously, resulting in the formation of a relatively
stable ternary complex. The CH-ILKBP–ILK–PINCH
complex together with other CH-ILKBP-, ILK-, and
PINCH-binding proteins provides an important physical
connection at FAs, linking the ECM to the actin cyto-
skeleton. Consistent with the notion that ILK recruits
CH-ILKBP to FAs where PINCH–ILK–CH-ILKBP provides
an anchor for the actin filaments, the association of the
ILK-binding defective mutants (DCH2 or F271D) with
the Triton X-100–insoluble cytoskeleton was significantly
reduced (our unpublished preliminary data). Using cells
that were either transiently or stably overexpressing mu-
tant forms of CH-ILKBP, we have obtained important
functional evidence supporting this model. Cells overex-
pressing the ILK-binding CH2 fragment exhibited signifi-
cant reductions in cell matrix adhesion, actin stress fiber
formation, and spreading. However, it is interesting to
note that the adhesion and spreading of the cells overex-
pressing the ILK-binding CH2 fragment were only par-
tially impaired. Besides the technical considerations (for
example, the transfection efficiency or the expression
level of the CH2 fragment), this likely reflects the fact
that there are multiple protein complexes, including those
containing talin, filamin, or a-actinin, that can physically
link the ECM and transmembrane receptors to the intra-
cellular actin cytoskeleton (Jockusch et al., 1995; Burridge
and Chrzanowska-Wodnicka, 1996; Calderwood et al.,
2000).
Cell adhesion is an essential cellular function of all mul-
ticellular organisms. Recent studies suggest that cells in
different organisms ranging from nematodes to human use
strikingly similar strategies to mediate this fundamental
process (Hynes and Zhao, 2000). In genetic model system
C. elegans, mutations in genes encoding integrin a (pat-2)
or b (pat-3) cause a PAT phenotype characterized by de-
fects in muscle dense body and M-lines, which resemble
FAs in mammalian cells (Williams and Waterston, 1994;
Gettner et al., 1995). Recent genetic studies have shown
that lack of PAT-4–ILK [Mackinnon, A.C., and B.D. Wil-
liams. 2000. 40th American Society for Cell Biology Annual
Meeting. 2664. (Abstr.)]or UNC-97–PINCH (Hobert et
al., 1999) in C. elegans results in a phenotype that is identi-
cal to that of the integrins. These studies provide strong ge-
netic evidence for a crucial role of the ILK and its binding
partner PINCH in the integrin-mediated cell adhesion.
Like ILK and PINCH, CH-ILKBP is an ancient protein
with homologues found in different organisms including C.
elegans. Human CH-ILKBP shares significant sequence
similarity with a predicted C. elegans protein (T21D12.4
protein) (Fig. 1 A). Recently, Lin and Williams [Lin, X.,
and B.D. Williams. 2000. 40th American Society for Cell
Biology Annual Meeting. 2666. (Abstr.)] presented genetic
Figure 9. Effects of CH-ILKBP on CHO cell adhe-
sion. (A–D) FLAG-tagged CH-ILKBP (lane 2),
F271D (lane 3), CH2 (residues 222–372) (lane 4),
and DCH2 (residues 1–229) (lane 5) were immuno-
precipitated from CHO cells transfected with the
corresponding FLAG expression vectors. (Lane 1)
Anti-FLAG immunoprecipitates obtained with the
vector control cells. The immunoprecipitates were
analyzed by Western blotting with anti-FLAG (A),
anti-ILK (B), or antipaxillin (C) antibodies. In D, the
membrane used in C was reprobed (without striping)
with anti-PINCH antibodies. Positions of FLAG–
CH-ILKBP (or F271D), FLAG-DCH2, FLAG–
CH2, ILK, paxillin, and PINCH were indicated.
(Lanes 6–9) Lysates (15 mg/lane) of the transfectants
as indicated. (E) Cell adhesion. Cells (as indicated in
the figure) were allowed to adhere to collage IV–
coated 96-well plates for 90 min, and the adhered
cells were quantified as described in Materials and
Methods. Under the condition used, z70% of the
vector control cells adhered. The adhesion effi-
ciency of CHO cells expressing different forms of
CH-ILKBP was compared with that of the vector
control cells and presented as percentages of that of
the control cells. Data represent the mean 6 SD of
two separate experiments.The Journal of Cell Biology, Volume 153, 2001 596
Figure 10. Effects of CH-ILKBP on C2C12 cell adhesion and
spreading. (A) Lysates (15 mg/lane) of independent C2C12
clones expressing the FLAG-tagged proteins were probed with
anti–FLAG-antibody M2. (Lane 1) FLAG–CH-ILKBP clone
A28; (lane 2) FLAG–CH-ILKBP clone A31; (lane 3) FLAG-
CH2 (residues 222–372) clone B20; (lane 4) FLAG-CH2 clone
B45; (lane 5) FLAG-DCH2 (residues 1–229) clone C31; (lane 6)
FLAG-DCH2 clone C46; (lane 7) lysates (15 mg) from the vector
control cells. (B) Cell adhesion. Cells (as indicated in the figure)
were allowed to adhere to collage I–coated 12-well plates for 30
min and were then washed. Cell adhesion is presented as the
number of adhered cells (after wash) divided by the number of
total cells (before wash). Data represent the mean 6 SD of four
randomly selected fields. (C and D) Cell spreading. C2C12 cells
expressing different forms of CH-ILKBP were seeded in collage
I–coated 12-well plates. The cell morphology was recorded 0.5
and 2 h after seeding (D). The percentage of cells adopting
spread morphology 0.5 h after seeding was quantified by analyz-
ing .300 cells from three randomly selected fields (C). Data rep-
resent mean 6 SD. (E) C2C12 cells overexpressing FLAG-CH2
(clone B45) and the vector control cells were plated on collage
I–coated slides for 0.5 or 2 h and stained with rhodamine-labeled
phalloidin. Identical results were obtained with clone B20. Bars:
(D) 100 mm; (E) 5 mm.Tu et al. A New ILK-binding Protein 597
evidence showing that C. elegans gene T21D12.4 corre-
sponds to another PAT gene, pat-6. Thus, the CH-ILKBP–
ILK–PINCH complex described in this paper likely repre-
sents an evolutionally well-conserved link between cell
adhesion receptors and the actin cytoskeleton. Zervas et
al. (2001) reported recently that mutations in Drosophila
ILK cause defects similar to loss of integrin adhesion, and
the actin filaments were detached from the membrane at
the muscle attachment sites in these mutants. Given the
fact that homologues of ILK, CH-ILKBP, and PINCH are
present in Drosophila, a CH-ILKBP–ILK–PINCH com-
plex that is analogous to the complex in mammalian cells
likely exists in Drosophila and provides an essential con-
nection linking the actin cytoskeleton to the adhesion sites
in Drosophila and in other organisms.
The data obtained in this and other studies suggest that
ILK is a protein with dual functions. The first function is to
provide a molecular scaffold for the assembly of the
PINCH–ILK–CH-ILKBP complex as shown in this study,
which together with other interactive proteins at FAs links
ECM to the actin cytoskeleton. The second function is to
serve as a protein kinase in the regulation of gene expres-
sion, survival, differentiation, and proliferation (Hannigan
et al., 1996; Radeva et al., 1997; Delcommenne et al., 1998;
Novak et al., 1998; Wu et al., 1998; Huang et al., 2000; Per-
sad et al., 2000). Given the importance of compartmental-
ization in kinase action during signal transduction, it is
likely that the protein–protein interactions mediated by
ILK, including that between ILK and CH-ILKBP, are in-
volved not only in cell adhesion, actin cytoskeleton organi-
zation, and spreading as shown in this study but also in
other ILK-regulated processes.
Northern blotting analyses indicate that CH-ILKBP is a
member of a family of structurally related proteins (Fig. 1
B). When this manuscript was in preparation, Nikolopou-
los and Turner (2000) described a new paxillin- and actin-
binding protein termed actopaxin. Actopaxin is struc-
turally related to CH-ILKBP (human actopaxin is 98%
identical to human CH-ILKBP at the amino acid level and
90% identical at the cDNA level). Because the difference
between actopaxin and CH-ILKBP cDNA sequences is
significant and occurs throughout the sequences, they are
likely encoded by two different genes. However, the strik-
ing similarity in protein sequences suggests that they may
share certain common functions. Actopaxin contains a po-
tential ILK-binding sequence that is identical to that in
CH-ILKBP, suggesting that actopaxin may also function
as an ILK-binding protein. However, it is important to
note that although CH-ILKBP contains a potential paxil-
lin-binding sequence as defined by Nikolopoulos and
Turner (2000), we could not detect an association between
paxillin and CH-ILKBP in vivo, despite using several dif-
ferent cell types, including mouse C2C12 cells (Figs. 3 and
5), CHO cells (Fig. 9), human kidney 293 cells, and rat em-
bryo fibroblasts (REF-52) (our unpublished results), and
multiple experimental approaches (immunoprecipitation
of endogenous or epitope-tagged CH-ILKBP, PINCH, or
paxillin). On the other hand, in all of the cell types ana-
lyzed, we have readily detected a stable CH-ILKBP–ILK–
PINCH complex. Thus, although our results do not rule
out the possibility that paxillin could bind to CH-ILKBP
in vitro or under certain other conditions, they do suggest
that CH-ILKBP functions primarily as an ILK-binding
protein in cells.
In summary, we have identified a new ILK-binding pro-
tein and have shown that it plays an important role in cell
adhesion and spreading. The data presented here provide
new insights into the molecular mechanism by which ILK
functions at adhesion sites. The CH-ILKBP–ILK–PINCH
complex described in this report likely functions as an im-
portant scaffold in the assembly and signaling through cell
matrix adhesion sites.
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